Target intelligence / Profile preview

Plasmodium falciparum digestive vacuole function (DV (digestive vacuole))

Target
DV (digestive vacuole)
Molecular classification
Other
01

Overview

The Plasmodium falciparum digestive (food) vacuole is an acidic, lysosome-like organelle where the parasite degrades host red blood cell hemoglobin during the intra-erythrocytic stages; hemoglobin-derived heme is detoxified by crystallization into inert hemozoin within this compartment, while short peptides are exported to the parasite cytosol via transporters such as PfCRT; antimalarials including chloroquine and related 4-aminoquinolines act by disrupting hemozoin formation in the vacuole, and artemisinin activation is facilitated by heme within the vacuole, leading to widespread damage; vacuole biogenesis involves endocytosis through a cytostome and fusion of small endocytic vesicles, with vacuolar proteases (e.g., plasmepsins) and other proteins trafficked to the vacuole; alterations in PfCRT and Kelch-13 underlie key resistance mechanisms; released intact vacuoles in severe malaria can activate complement and coagulation, contributing to pathology.

Other names
food vacuoledigestive vacuoleDV
02

Mechanism of action

Inhibition of hemozoin formation within the digestive vacuole (e.g., chloroquine, amodiaquine); Heme-activated radical damage to parasite organelles after artemisinin activation in the vacuole environment

03

Biological functions

Hemoglobin degradationHeme detoxification via hemozoin formationIntracellular endocytosis and vesicle fusion (cytostome-derived)Acidic lysosome-like digestionPeptide transport to parasite cytosol
04

Disease associations

Infection
05

Safety considerations

Target is a parasite organelle rather than a single molecular entity, complicating target specificity and resistance mappingDrug resistance via transporter mutations (PfCRT) and altered endocytosis/trafficking (K13) can undermine efficacyPotential host-pathology from released digestive vacuoles activating complement and coagulation in severe malaria
06

Interacting drugs

Chloroquine

2 more in the full profile.

07

Biomarkers

Mutations in Plasmodium falciparum chloroquine-resistance transporter (PfCRT) associated with chloroquine resistanceKelch-13 mutations associated with artemisinin resistancePresence/release of hemozoin-containing digestive vacuoles in blood as a pathophysiological marker

Beyond the preview

Go deeper on Plasmodium falciparum digestive vacuole function (DV (digestive vacuole)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum digestive vacuole function (DV (digestive vacuole)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call